Fesarius Therapeutics
PrivateLast Round
Series A
Jun 10, 2026
Total Funding Raised
$28.63M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Fesarius Therapeutics is a bioregenerative medical technology company that develops solutions for wound care, reconstructive surgery, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fesarius Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Fesarius Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 10, 2026 | ||||
| Convertible Debt | Nov 1, 2023 | ||||
| Grant | Aug 16, 2023 | ||||
| Grant | Aug 8, 2023 |
Key People
Founding team and executive leadership
Fesarius Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| NIH RADx | Grant |
| Jefferson Life Sciences | Series A |
| American Society of Plastic Surgeons | Series A |
| Johnson & Johnson Innovation - JJDC | Series A |
| ASPS Ventures, LLC | Series A |
| New York Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
$20M round led by Jefferson Life Sciences.
- Jan 23, 2026
Monthly visitors increased 230% MoM.
Fesarius Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fesarius Therapeutics's valuation, stock price, and market status.